Yahoo Malaysia Web Search

Sign In

Search results

  1. alexion.comAlexion

    Alexion develops and provides innovative medicines for people with rare and devastating conditions. Learn about their stories, products, offices, and how they work with the rare disease community.

    • Our Inspiration

      Living With Rare Diseases. Rare diseases can be devastating...

    • Our Medicines

      New Haven, CT: Alexion Pharmaceuticals, Inc; 2015. Tonsgard...

    • Our Research

      Alexion is committed to collaborating with researchers on...

    • Our Commitment

      Applicants own and control the activity and any related...

    • Our Company

      Alexion is focused on developing and delivering...

    • Your Career

      In July 2021, Alexion was acquired by AstraZeneca, marking...

    • News & Media

      Alexion Pharmaceuticals, Inc. provides this data for...

    • Contact Us

      Contact Us. In order to direct your inquiry to the correct...

  2. en.wikipedia.org › wiki › Alexion_PharmaceuticalsAlexion Pharmaceuticals - Wikipedia

    Alexion Pharmaceuticals, a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases.

  3. alexion.com › our-company › about-usAbout | Alexion

    Alexion is a biopharmaceutical company that develops and delivers medicines for people with rare and devastating diseases. Learn about our history, values, culture, and achievements in transforming lives every day.

  4. alexion.com › our-medicines › medicinesMedicines | Alexion

    Alexion is a biopharmaceutical company that develops and commercializes innovative medicines for seven rare and devastating conditions. Learn about their products, indications, safety information and research efforts.

  5. Videos

    View all

  6. www.astrazeneca.com › acquisition-of-alexion-completedAcquisition of Alexion completed - AstraZeneca

    Jul 21, 2021 · AstraZeneca today completed the acquisition of Alexion Pharmaceuticals, Inc. (Alexion). The closing of the acquisition marks the Company’s entry into medicines for rare diseases and the beginning of a new chapter for AstraZeneca.

  7. www.astrazeneca.com › astrazeneca-to-acquire-alexionAstraZeneca to acquire Alexion, accelerating the Company's...

    Dec 12, 2020 · Alexion's leading expertise in complement biology will accelerate AstraZeneca's growing presence in immunology. The acquisition adds a new technology platform to AstraZeneca's science and innovation-driven strategy. The complement cascade is pivotal to the innate immune system.

  8. www.astrazeneca.com › media-centre › press-releasesAstraZeneca receives US clearance of proposed acquisition of...

    Apr 16, 2021 · AstraZeneca’s proposed acquisition of Alexion Pharmaceuticals, Inc (Alexion) has achieved an important step toward completion, having cleared US Federal Trade Commission review. This follows the conclusion of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.